Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum Disorder
| dc.contributor.author | Siafis, Spyridon | |
| dc.contributor.author | Rodolico, Alessandro | |
| dc.contributor.author | Çiray, Oğulcan | |
| dc.contributor.author | Murphy, Declan G.m. | |
| dc.contributor.author | Parellada-Redondo, Mara José | |
| dc.contributor.author | Arango, Celso | |
| dc.contributor.author | Leucht, Stefan | |
| dc.date.accessioned | 2025-09-15T16:30:05Z | |
| dc.date.available | 2025-09-15T16:30:05Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Introduction: Response to treatment, according to Clinical Global Impression-Improvement (CGI-I) scale, is an easily interpretable outcome in clinical trials of autism spectrum disorder (ASD). Yet, the CGI-I rating is sometimes reported as a continuous outcome, and converting it to dichotomous would allow meta-analysis to incorporate more evidence. Methods: Clinical trials investigating medications for ASD and presenting both dichotomous and continuous CGI-I data were included. The number of patients with at least much improvement (CGI-I ≤ 2) were imputed from the CGI-I scale, assuming an underlying normal distribution of a latent continuous score using a primary threshold θ = 2.5 instead of θ = 2, which is the original cut-off in the CGI-I scale. The original and imputed values were used to calculate responder rates and odds ratios. The performance of the imputation method was investigated with a concordance correlation coefficient (CCC), linear regression, Bland–Altman plots, and subgroup differences of summary estimates obtained from random-effects meta-analysis. Results: Data from 27 studies, 58 arms, and 1428 participants were used. The imputation method using the primary threshold (θ = 2.5) had good performance for the responder rates (CCC = 0.93 95% confidence intervals [0.86, 0.96]; β of linear regression = 1.04 [0.95, 1.13]; bias and limits of agreements = 4.32% [−8.1%, 16.74%]; no subgroup differences χ2 = 1.24, p-value = 0.266) and odds ratios (CCC = 0.91 [0.86, 0.96]; β = 0.96 [0.78, 1.14]; bias = 0.09 [−0.87, 1.04]; χ2 = 0.02, p-value = 0.894). The imputation method had poorer performance when the secondary threshold (θ = 2) was used. Discussion: Assuming a normal distribution of the CGI-I scale, the number of responders could be imputed from the mean and standard deviation and used in meta-analysis. Due to the wide limits of agreement of the imputation method, sensitivity analysis excluding studies with imputed values should be performed. © 2021 Elsevier B.V., All rights reserved. | en_US |
| dc.identifier.doi | 10.3390/brainsci11070908 | |
| dc.identifier.issn | 2076-3425 | |
| dc.identifier.issn | 0035-9157 | |
| dc.identifier.scopus | 2-s2.0-85110914396 | |
| dc.identifier.uri | https://doi.org/10.3390/brainsci11070908 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12514/9286 | |
| dc.language.iso | en | en_US |
| dc.publisher | MDPI AG | en_US |
| dc.relation.ispartof | Brain Sciences | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Continuous Outcomes | en_US |
| dc.subject | Dichotomous Outcomes | en_US |
| dc.subject | Meta-Analysis | en_US |
| dc.subject | Response | en_US |
| dc.title | Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum Disorder | |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.scopusid | 57191500943 | |
| gdc.author.scopusid | 57195995122 | |
| gdc.author.scopusid | 57219228164 | |
| gdc.author.scopusid | 7404062227 | |
| gdc.author.scopusid | 14040702000 | |
| gdc.author.scopusid | 6508338058 | |
| gdc.author.scopusid | 6508338058 | |
| gdc.bip.impulseclass | C5 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C4 | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | Artuklu University | en_US |
| gdc.description.departmenttemp | [Siafis] Spyridon, Department of Psychiatry and Psychotherapy, TUM Fakultät für Medizin, Munich, Germany; [Rodolico] Alessandro, Università degli Studi di Catania, Scuola di Medicina, Catania, Italy; [Çiray] Oğulcan, Department of Child and Adolescent Psychiatry, Mardin State Hospital, Artuklu, Mardin, Turkey; [Murphy] Declan G.m., Department of Forensic and Neurodevelopmental Sciences, King's College London, London, United Kingdom; [Parellada-Redondo] Mara José, Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Universidad Complutense de Madrid, Facultad de Medicina, Madrid, Spain; [Arango] Celso, Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Universidad Complutense de Madrid, Facultad de Medicina, Madrid, Spain; [Leucht] Stefan, Department of Psychiatry and Psychotherapy, TUM Fakultät für Medizin, Munich, Germany | en_US |
| gdc.description.endpage | 1080 | |
| gdc.description.issue | 7 | en_US |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q2 | |
| gdc.description.startpage | 908 | |
| gdc.description.volume | 11 | en_US |
| gdc.description.wosquality | Q3 | |
| gdc.identifier.openalex | W3178510352 | |
| gdc.identifier.pmid | 34356141 | |
| gdc.index.type | Scopus | |
| gdc.oaire.accesstype | GOLD | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.downloads | 2 | |
| gdc.oaire.impulse | 4.0 | |
| gdc.oaire.influence | 2.63029E-9 | |
| gdc.oaire.isgreen | true | |
| gdc.oaire.keywords | Continuous outcomes | |
| gdc.oaire.keywords | response | |
| gdc.oaire.keywords | dichotomous outcomes | |
| gdc.oaire.keywords | Brief Report | |
| gdc.oaire.keywords | Neurociencias | |
| gdc.oaire.keywords | 3211 Psiquiatría | |
| gdc.oaire.keywords | 610 | |
| gdc.oaire.keywords | Response | |
| gdc.oaire.keywords | Neurosciences. Biological psychiatry. Neuropsychiatry | |
| gdc.oaire.keywords | meta-analysis | |
| gdc.oaire.keywords | Meta-analysis | |
| gdc.oaire.keywords | response; meta-analysis; continuous outcomes; dichotomous outcomes | |
| gdc.oaire.keywords | Neurociencias (Medicina) | |
| gdc.oaire.keywords | 2490 Neurociencias | |
| gdc.oaire.keywords | continuous outcomes | |
| gdc.oaire.keywords | Dichotomous outcomes | |
| gdc.oaire.keywords | Psiquiatría | |
| gdc.oaire.keywords | RC321-571 | |
| gdc.oaire.keywords | Adult | |
| gdc.oaire.keywords | Male | |
| gdc.oaire.keywords | Sulfasalazine | |
| gdc.oaire.keywords | Stomatitis | |
| gdc.oaire.keywords | Crohn Disease | |
| gdc.oaire.keywords | Prednisolone | |
| gdc.oaire.keywords | Humans | |
| gdc.oaire.popularity | 4.717451E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 03 medical and health sciences | |
| gdc.oaire.sciencefields | 0302 clinical medicine | |
| gdc.oaire.sciencefields | 0301 basic medicine | |
| gdc.oaire.views | 0 | |
| gdc.openalex.collaboration | International | |
| gdc.openalex.fwci | 2.55128306 | |
| gdc.openalex.normalizedpercentile | 0.88 | |
| gdc.opencitations.count | 4 | |
| gdc.plumx.crossrefcites | 4 | |
| gdc.plumx.mendeley | 18 | |
| gdc.plumx.pubmedcites | 3 | |
| gdc.plumx.scopuscites | 5 | |
| gdc.scopus.citedcount | 5 | |
| relation.isOrgUnitOfPublication | 39ccb12e-5b2b-4b51-b989-14849cf90cae | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 39ccb12e-5b2b-4b51-b989-14849cf90cae |
